Basit öğe kaydını göster

dc.contributor.authorAkdoğan, Remzi Adnan
dc.contributor.authorKalkan, Yıldıray
dc.contributor.authorTümkaya, Levent
dc.contributor.authorAlacam, Hasan
dc.contributor.authorErdivanlı, Başar
dc.contributor.authorAydın, İbrahim
dc.date.accessioned2020-12-19T20:03:38Z
dc.date.available2020-12-19T20:03:38Z
dc.date.issued2014
dc.identifier.citationAkdogan, R.A., Kalkan, Y., Tumkaya, L., Alacam, H., Erdivanli, B., Aydin, I., (2014). Influence of infliximab pretreatment on ischemia/reperfusion injury in rat intestine. Folia Histochemica Et Cytobiologica, 52(1), 36-41. https://doi.org/10.5603/FHC.2014.0004
dc.identifier.issn0239-8508
dc.identifier.issn1897-5631
dc.identifier.urihttps://doi.org/10.5603/FHC.2014.0004
dc.identifier.urihttps://hdl.handle.net/11436/3208
dc.descriptionErdivanli, Basar/0000-0002-3955-8242;en_US
dc.descriptionWOS: 000335969500004en_US
dc.descriptionPubMed: 24802959en_US
dc.description.abstractThe Pringle maneuver is used in hepatic surgery to prevent blood loss but is associated with ischemia-reperfusion injury. To investigate the effect of infliximab on inflammation and apoptosis in rat intestinal mucosa during ischemia-reperfusion (IR) injury. A total of 30 male Wistar albino rats were equally divided into three groups to be subjected to (i) sham operation (sham), (ii) IR injury via Pringle maneuver (pringle) or (iii) infliximab (IFX) group (IFX was given at a dose 3 mg/kg for 3 days before IR injury). Following reperfusion period of 60 min., intestinal tissue and blood samples were taken and processed by standard histological methods. the Pringle maneuver and following reperfusion caused significant histopathological changes, increased serum transaminases' activity and the levels of oxidative stress markers and decreased glutathione peroxidase activity. IFX pretreatment partially prevented these changes. Infliximab pretreatment may protect intestinal mucosa against ischemia-reperfusion injury. Further studies are needed to investigate mechanism and evaluate safety and optimal dosing of IFX in humans exposed to the possible tissue damage by ischemia-reperfusion.en_US
dc.language.isoengen_US
dc.publisherVia Medicaen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPringle maneuveren_US
dc.subjectIschemia-reperfusion injuryen_US
dc.subjectTNFen_US
dc.subjectInfliximaben_US
dc.subjectCalcineurinen_US
dc.subjectCaspase 3en_US
dc.subjectTransaminasesen_US
dc.subjectOxidative stressen_US
dc.titleInfluence of infliximab pretreatment on ischemia/reperfusion injury in rat intestineen_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorAkdoğan, Remzi Adnan
dc.contributor.institutionauthorKalkan, Yıldıray
dc.contributor.institutionauthorTümkaya, Levent
dc.contributor.institutionauthorErdivanlı, Başar
dc.contributor.institutionauthorAydın, İbrahim
dc.identifier.doi10.5603/FHC.2014.0004
dc.identifier.volume52en_US
dc.identifier.issue1en_US
dc.identifier.startpage36en_US
dc.identifier.endpage41en_US
dc.ri.editoaen_US
dc.relation.journalFolia Histochemica Et Cytobiologicaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster